Research Reports

Report No. 009 spERt™ Technology - A Breakthrough Technology Based on the Activation of Collagen Secretion Mechanism
Report No. spERt™ Technology - A Breakthrough Technology Based on the Activation of Collagen Secretion Mechanism
009

Overview

Collagen is the most abundant extracellular matrix component protein that is synthesized mainly by fibroblasts, and functions as a major component of skin and bones, playing various roles in maintaining the body. Fibroblasts, which are responsible for synthesizing the large amounts of collagen required by the body, can be said to be “professional secretory cells” that have a mechanism for efficiently secreting collagen.
Nippi’s spERt™ technology, selective polyribosome assembly on the ER with three factors, is designed based on the highly efficient collagen biosynthesis mechanism of fibroblasts, which are “professional secretory cells”, and dramatically improves the productivity of proteins [1]. In particular, it can achieve extremely high yields even for so-called “difficult-to-express” proteins. In the production of large complex biopharmaceuticals such as antibody drugs, which are mainly produced using animal cell cultures. This technology improves the efficiency of the translational process for secreted proteins, which has not been practically applied to date.

Mechanism of Highly Efficient Procollagen Secretion by Fibroblasts

Characteristics of the Endoplasmic Reticulum in “Professional Secretory Cells”
Proteins that are secreted outside the cell are synthesized in the endoplasmic reticulum ( Endoplasmic Reticulum ; ER)Once synthesis has started on the ER membrane, the synthesized polypeptides are immediately transported into the ER, where it undergoes various quality control processes such as folding into the native structure and glycosylation. In other words, being transported to the ER is the first important step in the biosynthesis of procollagen molecules. Fibroblasts that secrete a lot of procollagen molecules contain a large amount of ER, and in particular, they have a well-developed rough ER*.

*Rough ER (rER): A type of endoplasmic reticulum that has ribosomes attached to it, which are the main component of protein synthesis machinery. The name comes from the fact that many ribosome particles can be observed on the membrane by electron microscope images.

Figure 1 shows an example of human fibroblasts observed by electron microscope. The rER of human fibroblasts are associated with many ribosome particles (polyribosomes) that are associated with mRNA to form beads on a thread-like structure (Figure 1a). When observed at a higher magnification, it can be seen that each polyribosome contains more than 20 particulate structures (Figure 1b). It has been found that these long polyribosomes associated with the mRNA on endoplasmic reticulum membrane play a major role in the highly efficient secretion of procollagen by human fibroblasts [1, 3].


Figure 1: Electron microscopic images of human fibroblasts, modified from [3]
When the surface of the endoplasmic reticulum membrane of human fibroblasts cultured under conditions that promote large-scale secretion of procollagen is observed using an electron microscope, many long-chain polyribosomes consisting of linked ribosome particles are observed.

p180/RRBP-1 protein, which is important for the formation of long polyribosomes in the endoplasmic reticulum
The formation of long polyribosomes, as shown in Figure 1, is inhibited when the culture conditions are changed to suppress procollagen secretion. We have focused on the p180 protein (Ribosome-binding protein 1, encoded by the RRBP1 gene in human), hereafter, p180, of the ER membrane as a protein that plays a quite important role in activating procollagen secretion, and have been analyzing its molecular mechanism in detail [2-5].
We found that p180 is essential for the formation of long-chain polyribosomes in the ER membrane during collagen secretion activation, and p180 exerts a selective effect. For example, when the p180 expression level is lowered, the amount of collagen and fibronectin secreted decreases, but the amount of other secreted proteins (such as tissue inhibitor of metalloproteinase-1, TIMP-1 and Matrix metalloproteinase-2, MMP-2) are not decreased [2]. When we analyzed the mechanism underlying this selective effect of p180/RRBP1, we identified a novel factor, the splicing factor, SF3b4, that works in cooperation with p180 works in collaboration with a novel factor, SF3b4 [1]. SF3b4 is normally found in the nucleus, but in fibroblasts that actively secrete collagen, it is also found in the ER, and when the SF3b4 content decreases, collagen secretion also decreases. Various analyses have shown that SF3b4, in cooperation with p180, is an essential factor in processes such as the formation of long polyribosomes, including procollagen mRNA, and the transfer of mRNA to the ER [1].

Development of the spERt™ technology

Applying the results of this research, we have developed the technology that enhances the protein translation mechanism on the ER. It is widely known that the amount of mRNA does not correlate with the amount of protein secretion. By inducing the activation of the translation apparatus on the endoplasmic reticulum membrane using the spERt™ technology, we can increase the productivity of secreted proteins. Furthermore, by combining it with a cis-element that interacts with SF3b4 and promotes the transfer of mRNA to the endoplasmic reticulum, it is possible to further increase productivity. See reference [1] for more details.

Fig. 2: Model of the mechanism of promoting polyribosome formation using the spERt™ technology

The effectiveness of this technology was examined using CHO cells (Figure 3). The activity of CHO cells transfected with p180 and SF3b4 was compared. The introduction of the spERt™ technology increased secretion to approximately three times (Figure 3). In addition, when a cis-element was combined, the increase was about nine times (Figure 3). Next, we investigated the effect of this technology on antibody production using a CHO cell line that had been previously transfected with this technology [1]. With this technology, we obtained many antibody-producing cell lines that showed higher productivity than the control (Fig. 4A). We investigated whether enhancement of the ER translational machinery actually occurred in these high-producing cell lines. We performed polyribosome analysis using a density gradient centrifugation method with a membrane fraction containing the ER. As expected, the amount of polyribosomes increased in the spERt™ technology introduced cell lines (Fig. 4B). This suggests that the activation of the ER translation apparatus is induced in these cell lines, and contributes to the increase in antibody production. In addition to the above, it has also been confirmed that spERt™ technology increases the efficiency of mRNA utilization in an additive and synergistic manner, which contributes to enhanced translation (for details, please refer to references 2-4).


Figure 3. Effect of the spERt™ technology, p180, SF3b4, and cis-element, on secretion activity by CHO cells (modified from reference 1).
Alkaline phosphatase (AP) was used as a secretion marker.


Figure 4. Construction of CHO cell lines using spERt™ technology.
A. Comparison of the distribution of antibody titer in antibody-producing cell lines established using spERt™ technology-transfected CHO cells and control CHO cells. B. In the cell lines with the highest yield of antibody, the heavy (i.e. long-chain) polyribosomes increased.

Summary

We have established the spERt™ technology, which improves the expression of recombinant proteins by taking advantage of the characteristics of fibroblasts, which biosynthesize large amounts of procollagen molecules. CHO cell lines that have adopted this technology are resistant to stress and express proteins with a high survival rate over long periods of time. Furthermore, this technology can be used in conjunction with various existing technologies. We are currently expanding its application to Difficult-to-express proteins in various fields, as well as antibody drugs.

References

1. Ueno T, Taga Y, Yoshimoto R, Mayeda A, Hattori S, Ogawa-Goto, K. Component of splicing factor SF3b plays a key role in translational control of polyribosomes on the endoplasmic reticulum. Proc Natl Acad Sci U S A, 116, 9340-9349 (2019)
2. Ueno T, Tanaka K, Kaneko K, Taga Y, Sata T, Irie S, Hattori S, Ogawa-Goto, K. Enhancement of procollagen biosynthesis by p180 through augmented ribosome association on the endoplasmic reticulum in response to stimulated secretion. J Biol Chem, 285, 29941-29950 (2010)
3. Ueno T, Kaneko K, Sata T, Hattori S, Ogawa-Goto K. Regulation of polysome assembly on the endoplasmic reticulum by a coiled-coil protein, p180. Nucleic Acids Res, 40, 3006-3017 (2012)
4. Ogawa-Goto K, Tanaka K, Ueno T, Kurata T, Sata T, Irie S. p180 is involved in the interaction between the endoplasmic reticulum and microtubules through a novel microtubule-binding and bundling domain. Mol Biol Cell, 18, 3741-3751 (2007)
5. Ueno T, Kaneko K, Katano H, Sato Y, Mazitschek R, Tanaka K, Hattori S, Irie S, Sata T, Ogawa-Goto K. Expansion of the trans-Golgi network following activated collagen secretion is supported by a coiled-coil microtubule-bundling protein, p180, on the ER. Exp Cell Res, 316, 329-340 (2010)